-
-
-
-
-
-
-
CareDx, Inc (CDNA) PT Raised to $35 at Craig-Hallum
-
-
-
-
-
-
-
CareDx (CDNA) files mixed shelf
-
-
-
-
-
-
-
CareDx reports preliminary Q4 revenue growth of 25% year-over-year
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on CareDx, Inc (CDNA)
-
-
-
-
-
-
-
CareDx announces draft coverage policy for transplant rejection testing
-
-
-
-
-
-
-
CareDx (CDNA) Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
-
-
-
-
-
-
-
CareDx (CDNA) and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
-
458,135 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

